Scinai Immunotherapeutics Ltd. - SCNI

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2024 · Q4 2023
Value (USD)
Total reported value ($000)
$79K
QoQ value delta ($000)
-$63K (-44.37%)
Implied price effect (QoQ)
-14.15%
Shares
Total shares
156,448
QoQ shares delta
-84,966 (-35.2%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SCNI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2024)

Top 25 only Full list
Early Q2 2026 data: only 11 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ARMISTICE CAPITAL, LLC 63 121,785 0.0%
CITADEL ADVISORS LLC 6 12,214 0.0%
MILLENNIUM MANAGEMENT LLC 5 10,613 0.0%
RHUMBLINE ADVISERS 3 6,654 0.0%
MORGAN STANLEY 1 2,579 0.0%
UBS Group AG 1 2,118 0.0%
ROYAL BANK OF CANADA 0 4 0.0%
CREDIT AGRICOLE S A 0 424 0.0%
Qube Research & Technologies Ltd 0 7 0.0%
Global Retirement Partners, LLC 0 50 0.0%